+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biktarvy"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030 - Product Thumbnail Image

HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Genvoya ([elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)]; Gilead/Japan Tobacco) Drug Overview 2019 - Product Thumbnail Image

Genvoya ([elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)]; Gilead/Japan Tobacco) Drug Overview 2019

  • Report
  • June 2019
  • 15 Pages
  • Japan
HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • November 2023
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Biktarvy is a combination drug used to treat HIV/AIDS. It is a single-tablet regimen that combines three antiretroviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Biktarvy is used to treat HIV-1 infection in adults and adolescents aged 12 years and older. It is also used to reduce the risk of HIV-1 infection in adults and adolescents who are at high risk of HIV-1 infection. Biktarvy works by blocking the action of the virus in the body, preventing it from multiplying and spreading. The Biktarvy market is a rapidly growing segment of the HIV/AIDS drugs market. It is a highly competitive market, with several companies offering their own versions of the drug. Companies in the Biktarvy market include Gilead Sciences, Mylan, and ViiV Healthcare. Show Less Read more